middle.news
Dimerix secures A$17 million runway for two kidney drug trials
8:36am on Wednesday 23rd of September, 2026 AEST
•
Biotechnology
Read Story
Dimerix secures A$17 million runway for two kidney drug trials
8:36am on Wednesday 23rd of September, 2026 AEST
Key Points
A$17 million initial drawdown completed under A$34 million facility
Funding intended to support ACTION3 Phase 3 and DMX-652 Phase 2 activities
A further A$17 million remains available until 31 March 2027
Facility commitments could rise to A$50 million under its terms
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Dimerix (ASX:DXB)
OPEN ARTICLE